Relmada Therapeutics, Inc.

RLMD ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2018

Total Assets: $3.0M

Liabilities Breakdown FY2018

Total Liabilities: $8.6M